New structures come into view in brain wiring maps

Researchers at Harvard Medical School and the University of California San Diego have sped up a powerful imaging technique enough to map, for the first time, large volumes of brain tissue in nanoscale detail. The approach reveals fine structures that brain wiring maps, known as connectomes, can miss.

Despite soaring demand for GLP-1s, many eligible patients are unable to access these drugs for weight loss

In just a few short years, glucagon-like peptide-1 (GLP-1) receptor agonists have surged in popularity across the United States, transforming from specialized treatments for type 2 diabetes into revolutionary therapeutics for weight management, cardiovascular health and other emerging uses. But not all populations are benefiting from this expansion. As GLP-1 use has increased, disparities in access to these drugs have widened significantly, according to a new study led by researchers at Boston University School of Public Health (BUSPH).

Giving patients a greater voice in their diabetes care

In two related papers published in JAMA Network Open and the Journal of General Internal Medicine, Kasia Lipska, M.D., associate professor of medicine (endocrinology) at Yale School of Medicine (YSM) and her colleagues tested a new approach to incorporating patients' priorities into their diabetes care.